Study: Pfizer’s Paxlovid COVID Pill Showed No Measurable Benefit In Adults 40 To 65

Study: Pfizer’s Paxlovid COVID Pill Showed No Measurable Benefit In Adults 40 To 65

Pfizer’s COVID pill reportedly offered no measurable benefit for adults 40 to 65, according to a study published on Wednesday.

The Israeli study was conducted among 109,000 patients who were 40 years old or older.

READ MORE
 

Study: Pfizer’s Paxlovid COVID Pill Showed No Measurable Benefit In Adults 40 To 65

Pro-lifers Hold ‘Day of Tears’ for Roe v. Wade

Pro-lifers recognized the annual "Day of Tears" to remember…
Read more

GOP Pushes Back on Gun Control

The Democrats are calling for gun-control, and the Republicans…
Read more

Boris Johnson to Mandate Vaccine Passports

Boris Johnson recently gave the green light for the landlords…
Read more